Albany Molecular Research Inc. (AMRI) provides state-of-the-art facilities and capabilities to deliver integrated pharmaceutical drug development programs through clinical to commercial. We help clients assess and choose the best solid form for progression into animal and human dosing trials.
In the area of pharmaceutical development, our Pre-Formulation Development, Formulation Services, Process Development, and Analytical Services are available for a variety of dosage forms, from Powder-in-a-Bottle (PIB) and capsules to advanced oral, topical and sterile formulations. AMRI also has the capabilities required to provide a reliable and cost-effective supply of drug product through commercial production, as well as API from pre-clinical to post-NDA commercial production.
Available individually or integrated with other areas, AMRI offers development services at its locations in the United States, Europe and Asia.
AMRI has become the preferred choice for an ever increasing number of pharmaceutical and biotechnology companies seeking a partner for the rapid advancement of their drug candidates. AMRI's dynamic team is eager to take on any challenge – rapid development, scale-up to produce material for preclinical trials, or development of a cost-effective and robust manufacturing process. AMRI scientists have the experience and infrastructure available to make your project a success story.